75N95024F00169↗
A P Ventures, LLC received this contract from National Institutes of Health Nida, National Institutes of Health: $7.66M obligated so far for support- professional: other. It runs to 2027-07-28.
Key facts · data as of Oct 25, 2026
- Recipient
- A P Ventures, LLC
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nida (75N950)
- Obligated to date
- $7.66M
- Potential value
- $7.66M
- Ends
- 2027-07-28
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N95024F00169, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N95024F00169_7529_GS35F281CA_4732
A P Ventures, LLC: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nida: what it buys · The follow-on: recompete brief
MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) INFORMATION CENTER AND RELATED PROGRAMS
Up for re-bid: ends 2027-07-28. Recompete brief →
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Custom Computer Programming Services (NAICS 541511)
- Contracting office
- National Institutes of Health Nida (75N950)
- Competition
- Full and open competition · 2 offers received
- Set-aside
- WOSB
- Pricing
- Time and materials
- How it was bought
- GSA Schedule · under GS35F281CA
- Solicitation
- 75N95024Q00565
- Where the work is
- Howard, MD · district MD-03
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
5 actions since 2024-09-26. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-09 | P00004 | Funding only | $85.0K | NCATS - MODIFICATION TO FUND THE FDA PORTION OF OPTION PERIOD TWO (CONTRACT YEAR 3) OF THE MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) CONTRACT. - SEVERABLE |
| 2026-07-28 | P00003 | Option exercised | $2.70M | NCATS - MODIFICATION TO EXERCISE OPTION PERIOD TWO (CONTRACT YEAR 3) OF THE MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) CONTRACT. - SEVERABLE |
| 2025-07-24 | P00002 | Option exercised | $2.55M | MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) INFORMATION CENTER AND RELATED PROGRAMS. TO REDUCE THE AMOUNT OF OPTION PERIOD 1 (CONTRACT YEAR 2) FROM $2,647,304 TO $2,548,663.00. ADDITIONALLY, TO EXERCISE THIS OPTION AT TH |
| 2024-11-18 | P00001 | Supplemental agreement (work within scope) | $0 | MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) INFORMATION CENTER AND RELATED PROGRAMS |
| 2024-09-26 | 0 | $2.33M | MANAGEMENT AND RESEARCH SUPPORT FOR THE GENETIC AND RARE DISEASES (GARD) INFORMATION CENTER AND RELATED PROGRAMS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗